Clinical Trial Update: A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study in healthy volunteers to investigate a new medicine for malaria conducted by GlaxoSmithKline has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 1 | Status: TERMINATED